Tuesday, March 18, 2025
wellness India Expo
Home Tags 2025

Tag: 2025

India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

BioVoice News and the International Contract Pharma Association (ICPA) have collaborated to present an exclusive publication that will highlight India’s leadership in biotech and provide a powerful platform for companies to maximize their presence

Aster Guardians Global Nursing Award 2025 worth $250,000 extends nomination deadline...

The deadline for submissions is extended due to an overwhelming global response of 100,000+ registrations from 200+ countries

Neovantage Innovation Park showcases its life-sciences infrastructure at BioAsia 2025

Hosts ministerial visit and Miltenyi Biotec inauguration during the recently held mega show at Hyderabad

Telangana Life Sciences sector gets a major boost at BioAsia 2025

Strategic partnerships by the Telangana Government to advance the life sciences ecosystem

BioAsia 2025: C4IR Telangana & WEF to spearhead high-level dialogues on...

To unlock the potential of digital health with private workshops on bio-economy growth and holistic workforce health solutions

Countdown begins to BioAsia 2025: A unique platform to showcase startup...

Event will unlock the doors to exclusive interactions with industry leaders, PE/VC Firms, incubators, government officials, regulatory and other influential Global Leaders

Sun Pharma features among top 5% of global pharma companies in...

780 companies have qualified for inclusion in The Sustainability Yearbook 2025 globally

NDFC(I) inaugurates 2nd edition of MEWA India 2025

MEWA India 2025 boasts over 300 exhibitors and representatives from more than 25 countries, including major players like the USA, Iran, and Australia

Global ECMO experts gather at Apollo Hospitals’ ELSACON 2025

More than 100 ECMO Expert doctors from different part of world and India joined in the training session

Emcure Pharma registers 18% revenue growth, 30% PAT in Q3 of...

Revenue from operations at Rs 1,963 Cr, up 17.7% YoY and PAT at 156Cr, up 30.3% YoY